Browsing by Author "Eberhardt, Kirsten Alexandra"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
- ItemHelicobacter pylori Coinfection Is Associated With Decreased Markers of Immune Activation in ART-Naive HIV-Positive and in HIV-Negative Individuals in Ghana(Oxford University Press, 2015-11-15) Phillips, Richard Odame; Eberhardt, Kirsten Alexandra; Sarfo, Fred Stephen; Dompreh, Albert; Kuffour, Edmund Osei; et. alBackground. Helicobacter pylori coinfection in human immunodeficiency virus (HIV) patients has been associated with higher CD4+ cell counts and lower HIV-1 viral loads, with the underlying mechanisms being unknown. The objective of this study was to investigate the impact of H. pylori infection on markers of T-cell activation in HIVpositive and HIV-negative individuals. Methods. In a cross-sectional, observational study, HIV patients (n = 457) and HIV-negative blood donors (n = 79) presenting to an HIV clinic in Ghana were enrolled. Data on clinical and sociodemographic parameters, CD4+/CD8+ T-cell counts, and HIV-1 viral load were recorded. Helicobacter pylori status was tested using a stool antigen test. Cell surface and intracellular markers related to T-cell immune activation and turnover were quantified by flow cytometry and compared according to HIV and H. pylori status. Results. Helicobacter pylori infection was associated with decreased markers of CD4+ T-cell activation (HLADR+ CD38+CD4+; 22.55% vs 32.70%; P = .002), cell proliferation (Ki67; 15.10% vs 26.80%; P = .016), and immune exhaustion (PD-1; 32.45% vs 40.00%; P = .005) in 243 antiretroviral therapy (ART)–naive patients, but not in 214 patients on ART. In HIV-negative individuals, H. pylori infection was associated with decreased frequencies of activated CD4+ and CD8+ T cells (6.31% vs 10.40%; P = .014 and 18.70% vs 34.85%, P = .006, respectively). Conclusions. Our findings suggest that H. pylori coinfection effectuates a systemic immune modulatory effect with decreased T-cell activation in HIV-positive, ART-naive patients but also in HIV-negative individuals. This findingmight, in part, explain the observed association of H. pylori infection with favorable parameters of HIV disease progression. Clinical Trials Registration. Clinicaltrials.gov NCT01897909.